A missense mutation (Asp250----Asn) in exon 6 of the human lipoprotein lipase gene causes chylomicronemia in patients of different ancestries

Y. Ma, B. I. Wilson, S. Bijvoet, H. E. Henderson, E. Cramb, G. Roederer, M. R. Ven Murthy, P. Julien, H. D. Bakker, J. J. Kastelein

Research output: Contribution to journalArticleAcademicpeer-review

37 Citations (Scopus)

Abstract

We have previously reported two common lipoprotein lipase (LPL) gene mutations underlying LPL deficiency in the majority of 37 French Canadians (Monsalve et al., 1990. J. Clin. Invest. 86: 728-734; Ma et al., 1991. N. Engl. J. Med. 324: 1761-1766). By examining the 10 coding exons of the LPL gene in another French Canadian patient, we have identified a third missense mutation that is found in two of the three remaining patients for whom mutations are undefined. This is a G to A transition in exon 6 that results in a substitution of asparagine for aspartic acid at residue 250. Using in vitro site-directed mutagenesis, we have confirmed that this mutation causes a catalytically defective LPL protein. In addition, the Asp250----Asn mutation was also found on the same haplotype in an LPL-deficient patient of Dutch ancestry, suggesting a common origin. This mutation alters a TaqI restriction site in exon 6 and will allow for rapid screening in patients with LPL deficiency
Original languageEnglish
Pages (from-to)649-653
JournalGenomics
Volume13
Issue number3
DOIs
Publication statusPublished - 1992

Cite this